SCHEMBL9995648

SCHEMBL9995648

CCCNCCCS(=O)(=O)CCC(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 1/20 0.35
CES1 P23141 5/20 0.34
FAAH O00519 3/20 0.34
CES2 O00748 2/20 0.34
EPHX1 P07099 1/20 0.33
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
RELA Q04206 4/20 0.31
CA1 P00915 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9995631 0.87 CYP2C19 (0.38) CES1FAAHCES2EPHX1TSHR
SCHEMBL9995606 0.83 CES1 (0.36) PAOXCES1FAAHCES2EPHX1
SCHEMBL9995634 0.82 CA3 (0.32)
SCHEMBL12073487 0.82 KDM4E (0.33)
SCHEMBL15012485 0.81 FAAH (0.44) CES1FAAHCES2EPHX1ALDH1A1
SCHEMBL9995647 0.79 CES1 (0.30) CES1FAAHCES2
SCHEMBL9995644 0.78 CES1 (0.32) CES1
SCHEMBL23177600 0.76 CES1 (0.34) CES1FAAHCES2
SCHEMBL18766847 0.76 TSHR (0.43) PAOXALDH1A1TSHR
SCHEMBL7836962 0.76 PAOX (0.38) PAOXALDH1A1TSHRRELACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585435-A1 6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS Bayer Intellectual Property GmbH (DE) 2013-05-01 EP disclosed
WO-2011161101-A1 6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-12-29 WO disclosed